Most of the biological effects of Acrp30 are mediated by its receptors, AdipoR1 and AdipoR2, which belong to the seven-transmembrane-domain receptor family and have been shown to have abnormal expression in various types of human cancer [3–5]. This evidence concerns the gene ADIPOR1 and cancer.